Source: MONTANA STATE UNIVERSITY submitted to NRP
RESEARCH ON INFECTIOUS DISEASES OF ANIMALS AND THEIR MANAGEMENT IN MONTANA
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1009093
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Jan 14, 2016
Project End Date
Dec 30, 2018
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
MONTANA STATE UNIVERSITY
(N/A)
BOZEMAN,MT 59717
Performing Department
Microbiology & Immunology
Non Technical Summary
Infectious disease causes considerable loss for livestock producers by reducing production of animal units and by reduced sales because of food safety concerns. The Microbiology and Immunology (MBI) Department is the only research unit in Montana focused on animal health, particularly on the study of infectious diseases of cattle, bison and sheep. New faculty members joining MBI are required to initiate new research projects. In addition, other faculty not on Montana Agricultural Experiment Station (MAES) funding may be hired to develop new short-term projects. These projects are in support of the respective missions of MAES and MBI. This departmental project is to be used by these scientists to generate data to enhance their existing MAES project(s), take advantage of unique opportunities and to enhance their competitiveness for grant funding from federal agencies, such as the USDA. Support is also provided to maintain and operate departmental research facilities. The short- and long-term objectives are the development of new drugs, vaccines, and diagnostic tools for fighting infectious diseases of livestock, humans, and wildlife. This includes scholarly discovery and dissemination of science and technology related to diseases affecting livestock and wildlife, as well as zoonotic diseases that can be transmitted to humans.
Animal Health Component
25%
Research Effort Categories
Basic
75%
Applied
25%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
3153410109030%
3043999104020%
3113599109020%
3113610107010%
3113810109020%
Goals / Objectives
The short- and long-term objectives of research in MBI are the development of new drugs, vaccines, and diagnostic tools for fighting infectious diseases of livestock, humans, and wildlife. This includes scholarly discovery and dissemination of science and technology related to diseases affecting livestock and wildlife, as well as zoonotic diseases that can be transmitted to humans. Newly awarded MAES and/or initiated projects that have also been peer-reviewed include:1. Molecular pathogenesis of West Nile Virus (New MAES Project). West Nile virus (WNV) is an emergent neuroinvasive pathogen that causes severe illness in a wide range of vertebrates, including horses. In recently published work, we reported a restriction that limits the number of alphaherpes virions infecting neurons (Taylor et al., 2012). I propose a series of experiments that aim to identify if neuroinvasive spread of WNV is restricted in the number of virions transmitted between cells and characterize the cellular antiviral signaling activated neuronal infection of WNV. By characterizing neuroinvasive spread of WNV, we will begin to understand how neuroinvasive viruses are controlled during zoonotic infections and understand the impacts on viral population biology and pathogenesis. IBC Protocol Numbers: 032-2014 (WNV), 08-2015 (recombinant Baculovirus) and IACUC Protocol: 2013-282. Genome editing though use of CRISPR technology (New MAES Project). Cas9 is a new RNA-guide technology that permits rapid and precise manipulation of plant and animal genomes. This new gene knockout system is revolutionizing molecular biology and the value of this technology is currently estimated in the billions. However, this technique has been primarily restricted to generating gene knockouts (i.e. search and delete functions). Knockouts are critical for determining the biological function of a specific gene, but the genetic basis of many plant and animal diseases are already known and the next major advance will be to design methods that facilitate precise repair of defective genes (i.e. search and replace functions). Here we propose lentiviral delivery of Cas9 to generate a genome-wide knockout library in human cells that will identify novel pathways that enhance Homology Directed Repair (HDR) of double-stranded DNA breaks. We anticipate that many of the human genes involved in HDR will have conserved functions in other animals and plants. Results from this screen will provide fundamental new insight into DNA repair mechanisms, and provide a foundation for designing the next generation of tools for "correcting" genetic disorders and engineering Ag related products for resistance to environmental stress, and improving food security for the rapidly expanding population. IBC Protocol 024-2014.3. Mucosal immunology in pigs (NIH pilot grant peer-review). This study seeks to obtain pilot data to evaluate the current zoonotic threat and the mechanisms of gastric pathogenesis for human Helicobacter suis (H. suis) infection. H. suis is a stomach-dwelling bacterium naturally found in pigs that has been associated with gastric lesions including gastric cancer in humans. The overall hypothesis is that H. suis is a relevant zoonotic pathogen that disrupts human gastric epithelial cell function by triggering inflammatory signaling. In summary, our study will elucidate inflammatory pathways induced by H. suis and will determine whether there is a need for further research into zoonotic H. suis infection. IBC protocol 042-2014.4. New vaccine development for Coxiella burnetii and Brucella abortus and melitensis (new project). Using novel virus-like particles, unique vaccine constructs are being developed for effective T cell immune responses against Coxiella and Brucella.5. Funding will also be provided for new faculty who develop animal health related projects. Possible projects include disease ecology of pneumonia in bighorn sheep and domestic sheep, and scouring diseases in cattle.
Project Methods
MBI scientists utilize state-of-the-art molecular approaches to address basic and applied problems in infectious disease research. These research programs require laboratories, large and small animal facilities, clinics, and modern research equipment, such as flow cytometers, DNA sequencers, and genomics analysis facilities. The study of agents, such as B. abortus require BSL-3 facilities approved for Select Agent work. Specific methods and procedures utilized are dependent upon program type and necessary protocols. New or existing faculty members must develop an understanding of Montana and regional issues and a more in-depth understanding of existing research programs, prior to developing their own MAES project proposals. All research will have appropriate IBC Protocol Numbers and IACUC Protocol approvals.1. Molecular pathogenesis of West Nile Virus. West Nile virus (WNV) is an emergent neuroinvasive pathogen that causes severe illness in a wide range of vertebrates, including horses. In recently published work, we reported a restriction that limits the number of alphaherpes virions infecting neurons (Taylor et al., 2012). A series of experiments that aim to identify if neuroinvasive spread of WNV is restricted in the number of virions transmitted between cells and characterize the cellular antiviral signaling activated neuronal infection of WNV will be done. By characterizing neuroinvasive spread of WNV, we will begin to understand how neuroinvasive viruses are controlled during zoonotic infections and understand the impacts on viral population biology and pathogenesis. IBC Protocol Numbers: 032-2014 (WNV), 08-2015 (recombinant Baculovirus) and IACUC Protocol: 2013-282. Genome editing though use of CRISPR technology. Cas9 is a new RNA-guide technology that permits rapid and precise manipulation of plant and animal genomes. This new gene knockout system is revolutionizing molecular biology and the value of this technology is currently estimated in the billions. However, this technique has been primarily restricted to generating gene knockouts (i.e. search and delete functions). Knockouts are critical for determining the biological function of a specific gene, but the genetic basis of many plant and animal diseases are already known and the next major advance will be to design methods that facilitate precise repair of defective genes (i.e. search and replace functions). Here we propose lentiviral delivery of Cas9 to generate a genome-wide knockout library in human cells that will identify novel pathways that enhance Homology Directed Repair (HDR) of double-stranded DNA breaks. We anticipate that many of the human genes involved in HDR will have conserved functions in other animals and plants. Results from this screen will provide fundamental new insight into DNA repair mechanisms, and provide a foundation for designing the next generation of tools for "correcting" genetic disorders and engineering Ag related products for resistance to environmental stress, and improving food security for the rapidly expanding population. IBC Protocol 024-2014.3. Mucosal immunology in pigs (NIH pilot grant peer-review). This study seeks to obtain pilot data to evaluate the current zoonotic threat and the mechanisms of gastric pathogenesis for human Helicobacter suis (H. suis) infection. H. suis is a stomach-dwelling bacterium naturally found in pigs that has been associated with gastric lesions including gastric cancer in humans. The overall hypothesis is that H. suis is a relevant zoonotic pathogen that disrupts human gastric epithelial cell function by triggering inflammatory signaling. In summary, our study will elucidate inflammatory pathways induced by H. suis and will determine whether there is a need for further research into zoonotic H. suis infection. IBC protocol 042-2014.4. New vaccine development for Coxiella and Brucella (new project). Using novel virus-like particles, unique vaccine constructs are being developed for effective T cell immune responses against Coxiella burnetii and Brucella sps. Vaccine constructs will be used to immunize animals, prior to challenge with with C. burnetii or Brucella sps. Proof of principle studies will be done in mice under BSL-3 containment. Immune reponses against each construct will also be measured in cattle as our main livestock model system. Here animals will be immunized with different doses of vaccine and then antibody titers and antigen-specific T cell responses measured at different times, post vaccination.5. Funding will also be provided for new faculty who develop animal health related projects. Possible projects include disease ecology of pneumonia in bighorn sheep and domestic sheep, and scouring diseases in cattle.

Progress 10/01/17 to 09/30/18

Outputs
Target Audience:Researchers in the field of veterinary immunology, infectious disease and medicine. Ultimate goal of efforts in this project is to develop novel treatments for diseases of relevance to the livestock industry. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided? Nothing Reported How have the results been disseminated to communities of interest?Primary approach has been through submission of research papers for publication in peer-reviewed journals. What do you plan to do during the next reporting period to accomplish the goals?For the coming year, we plan on supporting current and additional MAES projects, such as bovine scours, sheep pneumonia, Brucellosis, and helicobacter infection in pigs. Again, modest support for minor equipment/supply purchases and personnel will be provided.

Impacts
What was accomplished under these goals? The main objective of this project is to support development of new and supplement ongoing research projects in the department focused on animal health. Funding was provided to multiple MAES projects, which included Project #1 (Taylor), a Streptococcus project (Lei), a scouring disease project in cattle (Walk, paper reported last year), and new projects on Salomenlla induced enteritis (Kominsky), vaccine development in Mycoplasma ovipneumoniae infection in domestic sheep (Rynda-Apple) and use of bacteriophage as countermeasues against Salmonella infection in calves (Wiedenheft). Funding was mainly provided for small equiment and lab supplies to augment these projects. Per outputs, Dr. Taylor and Lei published papers in 2018 and Kominsky has another paper ready for submission. Rynda-Apple submitted for USDA funding to support her new project on M. ovipneumonia and on vaccine development for B. abortus. Wiedenheft is seeking funding for his bacteriophage work from industry in partnership with the institution

Publications

  • Type: Journal Articles Status: Published Year Published: 2017 Citation: Law G, Herr A, Cwick J, Taylor M. A New Approach to Assessing HSV-1 Recombination during Intercellular Spread. Viruses.; 2018 Apr 25;10(5):220.
  • Type: Journal Articles Status: Other Year Published: 2019 Citation: Blaseg N, Jenkins B, Swain S, Deuling B, Grifka-Walk H, Kominsky DJ. IL-10R1 Alters Colonic Epithelial Tissue Homeostasis Via Wnt-Signaling Inhibitor DKK1. In preparation for submission
  • Type: Journal Articles Status: Published Year Published: 2018 Citation: Lei B, Minor D, Feng W, Liu M. Hypervirulent Group A Streptococcus of Genotype emm3 Invades the Vascular System in Pulmonary Infection of Mice. Infect Immun. 2018 May 22;86(6).
  • Type: Journal Articles Status: Published Year Published: 2018 Citation: Liu M, Lei B. Pathogenesis of Hypervirulent Group A Streptococcus. Liu M, Lei B. Jpn J Med (Lond). 2018;1(6):269-275.


Progress 10/01/16 to 09/30/17

Outputs
Target Audience:Researchers in the field of veterinary immunology, infectious disease and medicine. Ultimate goal of efforts in this project is to develop novel treatments for diseases of relevance to the livestock industry. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided? Nothing Reported How have the results been disseminated to communities of interest?Primary approach has been through submission of research papers for publication in peer-reviewed journals. What do you plan to do during the next reporting period to accomplish the goals?For the coming year, we plan on supporting additional MAES projects, such as project #3 above whose PI is submitting her project for MAES funding this year and another new MAES project being developed by Dr. Douglas Kominsky (new faculty member)on Salmonella induced enteritis. Funding may also be provided for a new respiratory disease project being developed by another another new faculty member in the coming year. Again, modest support of minor equipment purchases and personnel will be provided.

Impacts
What was accomplished under these goals? The main objective of this project is to support development of new research projects in the department focused on animal health.Funding for this project was only made available for the last 3 months of the reporting period. Small amounts of funding were provided to multiple MAES supported projects, which included Projects #1 (Taylor) and #2 (Wiedenheft), a new scouring disease project in cattle (Walk), and a mastitis project (Voyich). Funding was provided for small equiment purchases. Personnel support was also provided. Per the latter, 0.3 FTE technical support was provided on a new MAES project focused on developing approaches to "cure" pathogenic bacteria of specific plasmids encoding virulence genes in a new bovine scours project. This project is directed by Dr. Seth Walk, who recieved a small USDA/NIFA Seed grant to initiate this work and has just established a new MAES project. Specific efforts focused on use of germ free mice to begin to look at specific bacterial islates under controlled in vivo environments. His recent publication is reported here and cites this specific grant. This project has contributed to the development of a large research effort in the department on the gut microbiome led by Dr. Walk. Drs. Taylor, Wiedenheft and Voyich have longer standing funded MAES projects and their productivity is reported on their "Reeport" submissions.

Publications

  • Type: Journal Articles Status: Accepted Year Published: 2017 Citation: Coryell M, Ping L, Wang Y, McAlpine M, McDermott TR, Walk ST. The gut microbiome is required for full protection against acute arsenic toxicity in mouse models. Nat Comm. In Press (accepted 8/15/2017).


Progress 01/14/16 to 09/30/16

Outputs
Target Audience: Nothing Reported Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided? Nothing Reported How have the results been disseminated to communities of interest? Nothing Reported What do you plan to do during the next reporting period to accomplish the goals?Modest funding will be provided to investigators outlined in the original proposal to enhance development and progress of their agriculture related projects and submission of future grant proposals. Planned projects that will recieve modest support include: Dr. Matthew Taylor focused on the study of West Nile virus infection of horses, Dr. Blake Wiedenheft focused on genome editing approaches, Dr. Bimczok focused mucosal immunology in pigs, as it relates to H. suis infection, and , perhaps, other projects in the department relevent to and supported by the Montana Agricultural Experiment Station. Funding will be used to support research operations in the investigators labs.

Impacts
What was accomplished under these goals? Though this project was accepted in January of 2016, funding was not made available until September of 2016. As such, no effort was made in the first reporting period, except for identifying projects to receive support as outined in the original grant.

Publications